Exhibit 107.1
CALCULATION OF FILING FEE TABLE
FORM S-8
(Form Type)
LYRA THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Plan | Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered (1) |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee | ||||||||
| 2020 Incentive Award Plan |
Equity | Common Stock, par value $0.001 per share | Rule 457(c) and 457(h) |
2,620,600 (2) | $0.1835 (3) | $480,880.10 | $153.10 per million dollars | $73.63 | ||||||||
| Total Offering Amounts (4) | $480,880.10 | $73.63 | ||||||||||||||
| Total Fee Offsets | $0 | |||||||||||||||
| Net Fee Due | $73.63 | |||||||||||||||
| 1. | In accordance with Rule 416(a) under the Securities Act of 1933, as amended (“Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued under the Lyra Therapeutics, Inc. 2020 Incentive Award Plan (the “Incentive Plan”) to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
| 2. | Consists of 2,620,600 shares of the Registrant’s Common Stock that are or may become issuable under the Incentive Plan pursuant to its terms. |
| 3. | Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of the Common Stock as reported on the Nasdaq Capital Market on March 11, 2025. |
| 4. | The Registrant does not have any fee offsets. |